TrialBMC infectious diseases2024

Clinical antiviral efficacy of favipiravir in early COVID-19 (PLATCOV): an open-label, randomised, controlled, adaptive platform trial.

Viravarn Luvira et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.